Raghu Ram

Ma'am, I just want to understand maybe from a 3- , 4-year point of view. So as you said, like the base business like the India and emerging markets would be growing at lower pac e and how should we look at the regulated market growth, ma'am? Like what do you see the potential for that? One is in terms of the potential and the second thing is we coming out of these regulatory issues.

According to you, what could be the timeline for clearing those USFDA issues? How much for timeline?